Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-09-10 15:58:05 |
Versijas komentārs | |
Teksts |
Olainfarm
Holds 2nd Quarter 2014 Investor Conference
Webinar
AS
„Olainfarm” invites shareholders, investors, mass media
representatives and other stakeholders to join its second quarter
2014 investor conference webinar scheduled on September 10, 2014
at 16:00 (EET). Webinar
will be hosted by the member of the management board Salvis Lapiņš.
The presentation will be in English. During the
webinar Salvis Lapiņš will inform about AS “Olainfarm”
latest activities and analyse the financial results of the second
quarter 2014. After the
presentation investors will be welcomed to ask
questions
The
enslosed presentation will be used during the
webinar. What is
webinar?
How to
join the webinar? Additional
information on the webinar For
more information on webinar service please visit:
http://www.nasdaqomxbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies
in Latvia with more than 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
35 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information
prepared by:
Salvis
Lapins
JSC
“Olainfarm”
Member
of the Management Board
Rupnicu
iela 5, Olaine, Latvia, LV 2114 |
Pielikumi |